Authors


Akbar K. Waljee, MD

Latest:

5-ASA to Sulfasalazine Drug Switch Program in Patients With Ulcerative Colitis

A 5-aminosalicylic acid (5-ASA) drug switch program switching from 5-ASA to sulfasalazine was instituted for insured patients with ulcerative colitis. Unanticipated barriers limited the number of patients who switched, but significant cost savings were still obtained.


James L. Rosenzweig, MD

Latest:

Diabetes Disease Management in Medicare Advantage Reduces Hospitalizations and Costs

A disease management program for Medicare Advantage patients with diabetes and coronary artery disease resulted in significantly reduced hospital admissions and total healthcare costs.


Robert D. Orzechowski, MBA

Latest:

Patient Satisfaction Surveys: A Continuous NCODA Initiative for Improvement Within the Oncology Dispensing Practice

NCODA presents findings from over 700 patient responses across the country to determine patient satisfaction over 4 categories: time, convenience, staff interaction, and overall satisfaction.





Nicole Silverman, MBA

Latest:

Using the NQF Measure Incubator to Develop Patient-Reported Outcome Performance Measures in Palliative Cancer Care

The National Quality Forum (NQF) Measure Incubator provides a platform for the development of patient-reported outcome performance measures in palliative cancer care, which is essential to understanding a cancer patient’s functional status and well being.


Catherine P. Kaminetzky, MD, MPH

Latest:

Impact of Clinical Training on Recruiting Graduating Health Professionals

A business case is made for medical centers to offer high-quality clinical training experiences to recruit graduating health professionals.


Bailey Ingraham, MS

Latest:

Cost of Dementia in Medicare Managed Care: A Systematic Literature Review

A systematic review of the literature reporting the cost of dementia among Medicare managed care plans found a limited and dated body of evidence.


Grant D. Lawless, MD

Latest:

Impact of Specialty Drugs on the Use of Other Medical Services

Biologic therapy for rheumatoid arthritis or multiple sclerosis was associated with lower use of some types of medical services within 2 to 3 years of initiation.


Rita Hanover, PhD

Latest:

Producing Comparable Cost and Quality Results From All-Payer Claims Databases

This paper describes a replicable process for standardizing disparate databases and methods to calculate cost and quality measures within and across states.


Lara Yoon, MPH

Latest:

Understanding and Improving Value Frameworks With Real-World Patient Outcomes

New value frameworks should incorporate real-world evidence that reflects patient treatment behavior, adherence to medication, and equity concerns arising from disparities in care.




R. Mark Gritz, PhD

Latest:

Medicare Diabetes Prevention Program: Where Are the Suppliers?

Despite the Medicare Diabetes Prevention Program now being a covered benefit, there is inadequate availability of suppliers to reach Medicare beneficiaries with prediabetes.



Lonny Reisman, MD, Chief Executive Officer, HealthReveal

Latest:

Clinical Efficacy: A Cost Containment Weapon for the 21st Century

Mitigating cost increases through preemptive care and clinical efficacy to reduce the disease burden of clinically at-risk patients.


Robert D. Hill, PhD

Latest:

Review of Veterans Health Administration Telemedicine Interventions

A review of exemplary VHA-sponsored telemedicine interventions indicates that telemedicine can efficiently address patient healthcare needs.


Andrea Baer, MS

Latest:

Reducing Barriers to Medication Access and Adherence for ACA and Medicaid Participants: A Peer-to-Peer, Community-Based Approach

How peer-to-peer, community support programs can educate and empower patients to become more adherent to treatments, which will improve outcomes and reduce healthcare costs.


Kelly M. Doran, MD, MHS

Latest:

Reasons for Emergency Department Use: Do Frequent Users Differ?

Frequent emergency department (ED) users gave similar reasons for using the ED rather than a clinic compared to other patients, including concerns around convenience, access, and quality.


Francesca E. Cunningham, PharmD

Latest:

Trends in Opioid and Nonsteroidal Anti-Inflammatory Use and Adverse Events

Opioid use incidence and prevalence rates decreased with implementation of an opioid safety initiative, whereas nonsteroidal anti-inflammatory drug rates remained constant. Rates of adverse events were higher among opioid users.


Sheri D. Pruitt, PhD

Latest:

Can a Virtual Coach Activate Patients? A Proof of Concept Study

This study demonstrates patient acceptance of a virtual health coach while waiting for the physician to enter the primary care exam room.


Dirk Soenksen, MS, MBA

Latest:

Impact of Dementia on Costs of Modifiable Comorbid Conditions

Alzheimer disease and other dementias (ADOD) have a substantial impact on the prevalence and costs of certain comorbid conditions compared with matched beneficiaries without ADOD.



Kent R. Bailey, PhD

Latest:

Costs of Venous Thromboembolism Associated With Hospitalization for Medical Illness

Venous thromboembolism during or after recent hospitalization for medical illness contributes a substantial economic burden to society across all hospital and ambulatory care delivered.



Christine Colombo, MBA

Latest:

Medical Homes and Cost and Utilization Among High-Risk Patients

A longitudinal case-control design was used to evaluate the effects of the patient-centered medical home model on medical costs and utilization among high-risk patients.



Brent Hamar, DDS, MPH

Latest:

Impact of a Scalable Care Transitions Program for Readmission Avoidance

The 30-day readmission risk was reduced 25% by a collaborative program model employing discharge planning and telephonic follow-up for high-risk patients with CMS penalty diagnoses.


Michelle Lampman, MA

Latest:

Medical Homes Require More Than an EMR and Aligned Incentives

Primary care teams implementing medical homes experience professional role confusion and interpersonal conflict, and require effective administrative leadership to ensure success during this transition.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo